# High-Altitude Hypoxia Injury: Systemic Mechanisms and Intervention Strategies on Immune and Inflammatory Responses

**Authors:** Jingman Zhang, Shujie Guo, Beiebei Dou, Yang Liu, Xiaonan Wang, Yingze Jiao, Qianwen Li, Yan Li, Han Chen

PMC · DOI: 10.3390/antiox15010036 · Antioxidants · 2025-12-26

## TL;DR

This paper reviews how high-altitude hypoxia causes health issues and explores immune and inflammatory mechanisms and potential treatments.

## Contribution

The paper systematically reviews injury mechanisms and intervention strategies for high-altitude diseases, emphasizing multi-level therapeutic approaches.

## Key findings

- Hypoxia-induced oxidative stress and inflammation are key in high-altitude pathologies.
- Functional foods like beetroot and herbal bioactives show therapeutic potential.
- Multi-targeted strategies including oxygenation and pathway modulation are promising.

## Abstract

High-altitude exposure poses significant health challenges to mountaineers, military personnel, travelers, and indigenous residents. Altitude-related illnesses encompass acute conditions such as acute mountain sickness (AMS), high-altitude pulmonary edema (HAPE), and high-altitude cerebral edema (HACE), and chronic manifestations like chronic mountain sickness (CMS). Hypobaric hypoxia induces oxidative stress and inflammatory cascades, causing alterations in multiple organ systems through co-related amplification mechanisms. Therefore, this review aims to systematically discuss the injury mechanisms and comprehensive intervention strategies involved in high-altitude diseases. In summary, these pathologies involve key damage pathways: oxidative stress activates inflammatory pathways through NF-κB and NOD-like receptor thermal protein domain-associated protein 3 (NLRP3) inflammasomes; energy depletion impairs calcium homeostasis, leading to cellular calcium overload; mitochondrial dysfunction amplifies injury through mitochondrial permeability transition pore (mPTP) opening and apoptotic factor release. These mechanisms could be converged in organ-specific patterns—blood–brain barrier disruption in HACE, stress failure in HAPE, and right heart dysfunction in chronic exposure. Promising strategies include multi-level therapeutic approaches targeting oxygenation (supplemental oxygen, acetazolamide), specific pathway modulation (antioxidants, calcium channel blockers, HIF-1α regulators), and damage repair (glucocorticoids). Notably, functional foods show significant therapeutic potential: dietary nitrates (beetroot) enhance oxygen delivery, tea polyphenols and anthocyanins (black goji berry) provide antioxidant effects, and traditional herbal bioactives (astragaloside, ginsenosides) offer multi-targeted organ protection.

## Linked entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091]
- **Chemicals:** acetazolamide (PubChem CID 1986), anthocyanins (PubChem CID 145858), astragaloside (PubChem CID 5488387), ginsenosides (PubChem CID 3086007)
- **Diseases:** acute mountain sickness (MONDO:0021811), high-altitude pulmonary edema (MONDO:0021811), high-altitude cerebral edema (MONDO:0021811), chronic mountain sickness (MONDO:0100434)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}
- **Diseases:** Hypoxia (MESH:D000860), HACE (MESH:D001929), Inflammatory (MESH:D007249), heart dysfunction (MESH:D006331), mitochondrial dysfunction (MESH:D028361), AMS (MESH:D000532), pulmonary edema (MESH:D011654), HAPE (MESH:C535833)
- **Chemicals:** oxygen (MESH:D010100), anthocyanins (MESH:D000872), calcium (MESH:D002118), astragaloside (-), ginsenosides (MESH:D036145), nitrates (MESH:D009566), polyphenols (MESH:D059808), acetazolamide (MESH:D000086)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12837745/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12837745/full.md

## References

169 references — full list in the complete paper: https://tomesphere.com/paper/PMC12837745/full.md

---
Source: https://tomesphere.com/paper/PMC12837745